En bref — Mintel predicts a Products to Systems shift: consumers no longer buy standalone products but assemble products, services and behaviours around a specific goal. Only 33% of global CPG launches are genuinely new, down from 43% a decade ago. For your Wellness ingredients, the stakes move from the active ingredient to its place within a system and the proof of its contribution.
Your ingredients within a system are now worth more wellness-wise than the same active sold on its own. That’s the “Products to Systems” shift announced by Mintel in its Global Predictions 2027: consumers no longer buy standalone products, they assemble products, services, technologies and behaviours to achieve a specific goal, whether sleep, energy or healthy ageing [1]. A framing figure: only 33% of last year’s global CPG launches were “genuinely new”, down from 43% a decade earlier, according to Mintel’s Global New Products Database [1].
The verdict: the active ingredient is no longer enough, its place in the system decides
Mintel defines a system as “an interconnected set of products, services, technologies and behaviours that people combine to achieve an outcome” [1]. In other words, the goal is the destination, the system is the route. What this changes for you: your active ingredient is no longer judged alone, but on what it contributes to an outcome the consumer actually feels.
The saturation symptom is quantified. One launch in twenty now carries a wellness claim, which dilutes the very meaning of the term [1]. When a sleep supplement coexists with a mattress, a wearable, an app and a behaviour change, isolating the contribution of a single component becomes difficult. Mintel identifies this attribution problem as the model’s central bottleneck.
For your R&D and marketing teams, the consequence is direct. Positioning your ingredients within a system requires documenting their contribution to the outcome, not just their dosage. An active ingredient that cannot prove what it adds to the routine becomes interchangeable.
Why is this wellness shift happening now, not in three years?
The context is twofold: a fast-growing market and innovation running out of steam. Mintel forecasts 7.5% growth for the US wellness market, reaching $3.35 trillion by 2030 [1]. Demand is not the problem. What’s missing is novelty.
The drop from 43% to 33% in genuinely new launches signals a ceiling [1]. When product innovation stalls, value shifts towards assembly, orchestration and measurement. Mintel poses the question head-on: have the most pressing and necessary products already been invented?
Conversational AI is accelerating the shift. It lets consumers start from the desired outcome (“sleep better”) rather than the category keyword (“melatonin supplement”) [1]. On concrete signals, Mintel observes that sleep support is being built throughout the day: dinner, snacking, a calming drink, supplements, laundry detergent, ambient fragrances, overnight skin repair [1]. The single bedtime category is giving way to a distributed routine.
Timing matters for your ranges. Waiting until systems close around a dominant orchestrator risks turning you into an interchangeable component within an ecosystem run by others.
The evidence: where sleep conversations are actually growing
Social conversation data tracked by Black Swan Data for Mintel (US market, September 2024 to September 2026; household May 2024 to May 2026) distinguishes mature signals from emerging ones around sleep [1]. The key point: growth is concentrated outside the historic categories.
| Category | Trend | Volume | Growth | Maturity |
|---|---|---|---|---|
| Snacking | Better Sleep Quality | 198 | +53% | Emerging |
| Supplements | Improves Sleep | 1,577 | +24% | Growing |
| Skin Care | Promotes Restoration | 86,702 | +14% | Growing |
| Beverages | Aids Sleep | 13,041 | +2% | Mature |
| Meals | Aids Sleep | 7,304 | -3% | Mature |
| Household | Before Sleep | 32,242 | -5% | Mature |
| Fragrances | Aids Sleep | 10,277 | -1% | Mature |
A reading for your formulators: “better sleep quality” snacking is growing 53% from a still-low volume of 198, a sign of an open territory [1]. Supplements are up 24%, night-time skincare up 14%. Fragrances and household, meanwhile, are declining. Your ingredients within a system for sleep have more to gain in emerging segments than in saturated categories.
The same logic applies in food and drink. Mintel documents “stacking”: 62% of British consumers say certain foods or drinks are part of their daily wellness routine [1]. And 66% of Britons who use functional foods to manage their health also take vitamins or supplements, while 54% use an exercise tracker [1]. Consumers are already stacking. The question is whether your active ingredient is part of the stack.
The attribution wall, and how your teams can get past it
The number one obstacle is efficacy attribution. In a five-component system, proving that your ingredient made the difference is a methodological headache. Mintel says it plainly: the real breakthrough will be the ability to turn data into decisions on dosage, ingredients, formats and behaviours [1].
Three concrete levers emerge from Mintel’s framework:
- Innovate for real routines. A new ingredient should reinforce an existing system rather than add a step the consumer will abandon [1].
- Own the measurement. Develop credible measurement capabilities: routine adherence, mental well-being, habit formation. A claim wins one trial, it no longer guarantees a lasting place [1].
- Speak the consumer’s metric. Mintel sums up its prediction “The Recommendation Engine Is the New Brand”: the data-driven consumer will be won over by the brands the engine can read, proven by what goes in, expressed in their own metrics [1].
A second, more political obstacle: loss of control. Mintel cites the Dutch litigation over PlayStation’s move away from physical media, a risk that a connected ecosystem could reduce consumers’ perceived ownership [1]. A poorly designed system can turn trust against you.
What the shift to systems redistributes for your investment decisions
For your procurement and innovation teams, the trade-off is shifting. Investing in one more standalone active ingredient pays off less than investing in proof of contribution, measurement partnerships, and integrating your ingredients within a system that consumers have already built.
The role you need to decide before reformulating
Mintel identifies four roles a brand can play within a system: component (improving one piece), connector (making separate elements work together), guide (helping decide what to use) or orchestrator (coordinating the whole and removing effort from the consumer) [1]. Before launching a range, ask: on sleep, energy or ageing, which of these roles does your expertise actually entitle you to hold?
Mintel goes further with its prediction “Wellness Is a Swear Word”: the word “wellness” would stop resonating, and consumers would reward brands whose benefit they can feel, at a fair price [1]. A strong signal for your marketing teams: the generic claim loses, the measurable, lived benefit wins.
That leaves the operational question every R&D director will have to settle this year: is your next launch still trying to exist as a standalone product, or does it start by mapping the system your target customer has already assembled around their goal?
References
Sources
FAQ
What does Mintel’s “Products to Systems” shift actually mean?
According to Mintel (Global Predictions 2027), consumers no longer buy standalone products but assemble products, services, technologies and behaviours to achieve a specific outcome, such as better sleep. Your ingredient is judged on its contribution to that outcome, not on its dosage alone.
Why is efficacy attribution becoming a problem for ingredient suppliers?
In a system where a supplement, a mattress, a wearable and an app all coexist, isolating the contribution of a single component is difficult, Mintel notes. The stakes shift towards credible measurement capabilities (adherence, well-being, habit formation) able to prove what your active ingredient actually adds.
Which wellness segments offer the most room for innovation around sleep?
Black Swan Data figures for Mintel (US, 2024-2026) show sleep conversation growth concentrated in snacking (+53%), supplements (+24%) and night-time skincare (+14%), while fragrances, household and meals are declining. Emerging territories offer more headroom than saturated categories.
How big is the wellness market and how fast is it growing?
Mintel forecasts 7.5% growth for the US wellness market, reaching $3.35 trillion by 2030. Demand remains strong, but the share of genuinely new CPG launches has fallen from 43% to 33% in a decade, shifting value towards assembly and measurement.
What role can my ingredient brand play within a system?
Mintel distinguishes four roles: component (improving one piece), connector (linking elements together), guide (helping consumers decide) and orchestrator (coordinating the whole system). The choice depends on the expertise, assets and trust your brand can legitimately bring to a given goal.
Is the term “wellness” still a good B2B marketing argument?
Mintel predicts that the word “wellness” will stop resonating and that consumers will reward brands whose benefit they can actually feel, at a fair price. For your teams, this means prioritising measurable, lived benefit over generic claims, already diluted by one in twenty launches.